Uganda to End Ebola Emergency; Africa CDC May Follow Suit with Mpox 24/04/2025 Stefan Anderson Uganda is set to declare an end to its Ebola outbreak on April 26 if no new cases emerge, Africa’s top public health agency announced Thursday. The country’s 83% recovery rate among confirmed cases significantly exceeds the typical 30-40% survival rate for Ebola outbreaks, with Uganda managing to contain the disease while simultaneously responding to […] Continue reading -> US Funding Freeze Hits Mpox Response in DRC; Ebola Trial Progresses in Uganda 13/02/2025 Paul Adepoju As Africa battles a relentless mpox outbreak, a sudden freeze in United States foreign aid is crippling containment efforts, threatening vaccine distribution, and leaving the hardest-hit regions scrambling for solutions, the Africa Centres for Disease Control and Prevention (Africa CDC) warned on Thursday. In conflict-ridden Democratic Republic of Congo (DRC), the epicentre of the outbreak, […] Continue reading -> Gavi Includes Ebola, Meningitis, Rabies and Hepatitis B Vaccines in its Portfolio 24/06/2024 Zuzanna Stawiska Gavi, the Vaccine Alliance, announced last week that it will offer high risk countries the option of obtaining preventative Ebola vaccines, particularly for health workers, as part of the rollout of new vaccine offerings, which also include meningitis, rabies and hepatitis B vaccines. Plans to add the vaccines to the basket of available products were […] Continue reading -> Marburg, Ebola Sudan Vaccines Might Get Share of COVAX Surplus 04/07/2023 Megha Kaveri Some of the $2.6 billion that remains in a COVID-19 vaccine delivery scheme, COVAX, could be redirected into investment into investigational vaccine candidates for Marburg Virus Disease (MVD) and Ebola Sudan strain virus, as well as over half a dozen other vaccine programmes that were suspended due to the pandemic or delays in product development, […] Continue reading -> After Ebola Scandal: Rooting Out Sexual Misconduct in WHO 31/01/2023 Kerry Cullinan A special unit to address sexual ‘misconduct’, a fund to support survivors in the Democratic Republic of Congo (DRC) and training for all staff are some of the steps taken by the World Health Organization (WHO) to rid itself of exploitative behaviour. This follows the scandal that played out during the Ebola outbreaks in the […] Continue reading -> With End of Uganda Outbreak, There is No Clear Path to Test the Ebola Sudan Candidate Vaccines 13/01/2023 Kerry Cullinan There is no clear path to test the three candidate vaccines developed to combat the Ebola Sudan strain now that Uganda’s outbreak is over. The three candidate vaccines – produced by IAVI (called SUDV), Sabin (ChAD3) and Oxford (ChAdOx1) – were delivered to Uganda with much fanfare in mid-December. But scientists attending a meeting convened […] Continue reading -> Novel Ways to Advance Sudan Ebolavirus Vaccine Candidates? Experts Meet as Uganda’s Outbreak Declared Over 11/01/2023 Elaine Ruth Fletcher WHO’s Africa Region has declared the end to the recent outbreak of Sudan Ebolavirus – just a day before WHO convenes Ebola experts in a global consultation to explore a way forward on testing three candidate vaccines for the deadly Sudan strain of the virus. The oubreak was declared over after the elapse of 44 […] Continue reading -> Exclusive: Vaccine Trial Against Sudan Ebolavirus – With No Recent Infections in Uganda, What’s Plan B? 23/12/2022 Elaine Ruth Fletcher The World Health Organization (WHO) isn’t talking about it publicly, but behind the scenes WHO is planning a meeting for 12 January to evaluate next steps, Health Policy Watch has learned, as the absence of new cases in the Uganda outbreak makes it impossible to begin a clinical trial based on a ring vaccination of […] Continue reading -> Uganda Extends Lockdowns in Bid to End Ebola Outbreak 28/11/2022 Stefan Anderson Uganda’s President Yoweri Museveni has extended quarantine measures in the two districts at the epicentre of the country’s Ebola epidemic for another 21 days, citing the need to protect gains in the fight against the virus. This marks the third renewal of lockdowns in Kassanda and Mubende, and authorities are hopeful it will be the […] Continue reading -> Trials of Three Ebola Candidate Vaccines Set for Uganda; India’s Covaxin Vaccine Still Suspended by WHO 16/11/2022 Megha Kaveri Clinical trials on three Ebola vaccine candidates for the Sudan strain of the virus are due to start soon in Uganda, according to the World Health Organization (WHO). “I’m pleased to announce that a WHO committee of external experts has evaluated three candidate vaccines and agreed that all three should be included in the planned […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
US Funding Freeze Hits Mpox Response in DRC; Ebola Trial Progresses in Uganda 13/02/2025 Paul Adepoju As Africa battles a relentless mpox outbreak, a sudden freeze in United States foreign aid is crippling containment efforts, threatening vaccine distribution, and leaving the hardest-hit regions scrambling for solutions, the Africa Centres for Disease Control and Prevention (Africa CDC) warned on Thursday. In conflict-ridden Democratic Republic of Congo (DRC), the epicentre of the outbreak, […] Continue reading -> Gavi Includes Ebola, Meningitis, Rabies and Hepatitis B Vaccines in its Portfolio 24/06/2024 Zuzanna Stawiska Gavi, the Vaccine Alliance, announced last week that it will offer high risk countries the option of obtaining preventative Ebola vaccines, particularly for health workers, as part of the rollout of new vaccine offerings, which also include meningitis, rabies and hepatitis B vaccines. Plans to add the vaccines to the basket of available products were […] Continue reading -> Marburg, Ebola Sudan Vaccines Might Get Share of COVAX Surplus 04/07/2023 Megha Kaveri Some of the $2.6 billion that remains in a COVID-19 vaccine delivery scheme, COVAX, could be redirected into investment into investigational vaccine candidates for Marburg Virus Disease (MVD) and Ebola Sudan strain virus, as well as over half a dozen other vaccine programmes that were suspended due to the pandemic or delays in product development, […] Continue reading -> After Ebola Scandal: Rooting Out Sexual Misconduct in WHO 31/01/2023 Kerry Cullinan A special unit to address sexual ‘misconduct’, a fund to support survivors in the Democratic Republic of Congo (DRC) and training for all staff are some of the steps taken by the World Health Organization (WHO) to rid itself of exploitative behaviour. This follows the scandal that played out during the Ebola outbreaks in the […] Continue reading -> With End of Uganda Outbreak, There is No Clear Path to Test the Ebola Sudan Candidate Vaccines 13/01/2023 Kerry Cullinan There is no clear path to test the three candidate vaccines developed to combat the Ebola Sudan strain now that Uganda’s outbreak is over. The three candidate vaccines – produced by IAVI (called SUDV), Sabin (ChAD3) and Oxford (ChAdOx1) – were delivered to Uganda with much fanfare in mid-December. But scientists attending a meeting convened […] Continue reading -> Novel Ways to Advance Sudan Ebolavirus Vaccine Candidates? Experts Meet as Uganda’s Outbreak Declared Over 11/01/2023 Elaine Ruth Fletcher WHO’s Africa Region has declared the end to the recent outbreak of Sudan Ebolavirus – just a day before WHO convenes Ebola experts in a global consultation to explore a way forward on testing three candidate vaccines for the deadly Sudan strain of the virus. The oubreak was declared over after the elapse of 44 […] Continue reading -> Exclusive: Vaccine Trial Against Sudan Ebolavirus – With No Recent Infections in Uganda, What’s Plan B? 23/12/2022 Elaine Ruth Fletcher The World Health Organization (WHO) isn’t talking about it publicly, but behind the scenes WHO is planning a meeting for 12 January to evaluate next steps, Health Policy Watch has learned, as the absence of new cases in the Uganda outbreak makes it impossible to begin a clinical trial based on a ring vaccination of […] Continue reading -> Uganda Extends Lockdowns in Bid to End Ebola Outbreak 28/11/2022 Stefan Anderson Uganda’s President Yoweri Museveni has extended quarantine measures in the two districts at the epicentre of the country’s Ebola epidemic for another 21 days, citing the need to protect gains in the fight against the virus. This marks the third renewal of lockdowns in Kassanda and Mubende, and authorities are hopeful it will be the […] Continue reading -> Trials of Three Ebola Candidate Vaccines Set for Uganda; India’s Covaxin Vaccine Still Suspended by WHO 16/11/2022 Megha Kaveri Clinical trials on three Ebola vaccine candidates for the Sudan strain of the virus are due to start soon in Uganda, according to the World Health Organization (WHO). “I’m pleased to announce that a WHO committee of external experts has evaluated three candidate vaccines and agreed that all three should be included in the planned […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Gavi Includes Ebola, Meningitis, Rabies and Hepatitis B Vaccines in its Portfolio 24/06/2024 Zuzanna Stawiska Gavi, the Vaccine Alliance, announced last week that it will offer high risk countries the option of obtaining preventative Ebola vaccines, particularly for health workers, as part of the rollout of new vaccine offerings, which also include meningitis, rabies and hepatitis B vaccines. Plans to add the vaccines to the basket of available products were […] Continue reading -> Marburg, Ebola Sudan Vaccines Might Get Share of COVAX Surplus 04/07/2023 Megha Kaveri Some of the $2.6 billion that remains in a COVID-19 vaccine delivery scheme, COVAX, could be redirected into investment into investigational vaccine candidates for Marburg Virus Disease (MVD) and Ebola Sudan strain virus, as well as over half a dozen other vaccine programmes that were suspended due to the pandemic or delays in product development, […] Continue reading -> After Ebola Scandal: Rooting Out Sexual Misconduct in WHO 31/01/2023 Kerry Cullinan A special unit to address sexual ‘misconduct’, a fund to support survivors in the Democratic Republic of Congo (DRC) and training for all staff are some of the steps taken by the World Health Organization (WHO) to rid itself of exploitative behaviour. This follows the scandal that played out during the Ebola outbreaks in the […] Continue reading -> With End of Uganda Outbreak, There is No Clear Path to Test the Ebola Sudan Candidate Vaccines 13/01/2023 Kerry Cullinan There is no clear path to test the three candidate vaccines developed to combat the Ebola Sudan strain now that Uganda’s outbreak is over. The three candidate vaccines – produced by IAVI (called SUDV), Sabin (ChAD3) and Oxford (ChAdOx1) – were delivered to Uganda with much fanfare in mid-December. But scientists attending a meeting convened […] Continue reading -> Novel Ways to Advance Sudan Ebolavirus Vaccine Candidates? Experts Meet as Uganda’s Outbreak Declared Over 11/01/2023 Elaine Ruth Fletcher WHO’s Africa Region has declared the end to the recent outbreak of Sudan Ebolavirus – just a day before WHO convenes Ebola experts in a global consultation to explore a way forward on testing three candidate vaccines for the deadly Sudan strain of the virus. The oubreak was declared over after the elapse of 44 […] Continue reading -> Exclusive: Vaccine Trial Against Sudan Ebolavirus – With No Recent Infections in Uganda, What’s Plan B? 23/12/2022 Elaine Ruth Fletcher The World Health Organization (WHO) isn’t talking about it publicly, but behind the scenes WHO is planning a meeting for 12 January to evaluate next steps, Health Policy Watch has learned, as the absence of new cases in the Uganda outbreak makes it impossible to begin a clinical trial based on a ring vaccination of […] Continue reading -> Uganda Extends Lockdowns in Bid to End Ebola Outbreak 28/11/2022 Stefan Anderson Uganda’s President Yoweri Museveni has extended quarantine measures in the two districts at the epicentre of the country’s Ebola epidemic for another 21 days, citing the need to protect gains in the fight against the virus. This marks the third renewal of lockdowns in Kassanda and Mubende, and authorities are hopeful it will be the […] Continue reading -> Trials of Three Ebola Candidate Vaccines Set for Uganda; India’s Covaxin Vaccine Still Suspended by WHO 16/11/2022 Megha Kaveri Clinical trials on three Ebola vaccine candidates for the Sudan strain of the virus are due to start soon in Uganda, according to the World Health Organization (WHO). “I’m pleased to announce that a WHO committee of external experts has evaluated three candidate vaccines and agreed that all three should be included in the planned […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Marburg, Ebola Sudan Vaccines Might Get Share of COVAX Surplus 04/07/2023 Megha Kaveri Some of the $2.6 billion that remains in a COVID-19 vaccine delivery scheme, COVAX, could be redirected into investment into investigational vaccine candidates for Marburg Virus Disease (MVD) and Ebola Sudan strain virus, as well as over half a dozen other vaccine programmes that were suspended due to the pandemic or delays in product development, […] Continue reading -> After Ebola Scandal: Rooting Out Sexual Misconduct in WHO 31/01/2023 Kerry Cullinan A special unit to address sexual ‘misconduct’, a fund to support survivors in the Democratic Republic of Congo (DRC) and training for all staff are some of the steps taken by the World Health Organization (WHO) to rid itself of exploitative behaviour. This follows the scandal that played out during the Ebola outbreaks in the […] Continue reading -> With End of Uganda Outbreak, There is No Clear Path to Test the Ebola Sudan Candidate Vaccines 13/01/2023 Kerry Cullinan There is no clear path to test the three candidate vaccines developed to combat the Ebola Sudan strain now that Uganda’s outbreak is over. The three candidate vaccines – produced by IAVI (called SUDV), Sabin (ChAD3) and Oxford (ChAdOx1) – were delivered to Uganda with much fanfare in mid-December. But scientists attending a meeting convened […] Continue reading -> Novel Ways to Advance Sudan Ebolavirus Vaccine Candidates? Experts Meet as Uganda’s Outbreak Declared Over 11/01/2023 Elaine Ruth Fletcher WHO’s Africa Region has declared the end to the recent outbreak of Sudan Ebolavirus – just a day before WHO convenes Ebola experts in a global consultation to explore a way forward on testing three candidate vaccines for the deadly Sudan strain of the virus. The oubreak was declared over after the elapse of 44 […] Continue reading -> Exclusive: Vaccine Trial Against Sudan Ebolavirus – With No Recent Infections in Uganda, What’s Plan B? 23/12/2022 Elaine Ruth Fletcher The World Health Organization (WHO) isn’t talking about it publicly, but behind the scenes WHO is planning a meeting for 12 January to evaluate next steps, Health Policy Watch has learned, as the absence of new cases in the Uganda outbreak makes it impossible to begin a clinical trial based on a ring vaccination of […] Continue reading -> Uganda Extends Lockdowns in Bid to End Ebola Outbreak 28/11/2022 Stefan Anderson Uganda’s President Yoweri Museveni has extended quarantine measures in the two districts at the epicentre of the country’s Ebola epidemic for another 21 days, citing the need to protect gains in the fight against the virus. This marks the third renewal of lockdowns in Kassanda and Mubende, and authorities are hopeful it will be the […] Continue reading -> Trials of Three Ebola Candidate Vaccines Set for Uganda; India’s Covaxin Vaccine Still Suspended by WHO 16/11/2022 Megha Kaveri Clinical trials on three Ebola vaccine candidates for the Sudan strain of the virus are due to start soon in Uganda, according to the World Health Organization (WHO). “I’m pleased to announce that a WHO committee of external experts has evaluated three candidate vaccines and agreed that all three should be included in the planned […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
After Ebola Scandal: Rooting Out Sexual Misconduct in WHO 31/01/2023 Kerry Cullinan A special unit to address sexual ‘misconduct’, a fund to support survivors in the Democratic Republic of Congo (DRC) and training for all staff are some of the steps taken by the World Health Organization (WHO) to rid itself of exploitative behaviour. This follows the scandal that played out during the Ebola outbreaks in the […] Continue reading -> With End of Uganda Outbreak, There is No Clear Path to Test the Ebola Sudan Candidate Vaccines 13/01/2023 Kerry Cullinan There is no clear path to test the three candidate vaccines developed to combat the Ebola Sudan strain now that Uganda’s outbreak is over. The three candidate vaccines – produced by IAVI (called SUDV), Sabin (ChAD3) and Oxford (ChAdOx1) – were delivered to Uganda with much fanfare in mid-December. But scientists attending a meeting convened […] Continue reading -> Novel Ways to Advance Sudan Ebolavirus Vaccine Candidates? Experts Meet as Uganda’s Outbreak Declared Over 11/01/2023 Elaine Ruth Fletcher WHO’s Africa Region has declared the end to the recent outbreak of Sudan Ebolavirus – just a day before WHO convenes Ebola experts in a global consultation to explore a way forward on testing three candidate vaccines for the deadly Sudan strain of the virus. The oubreak was declared over after the elapse of 44 […] Continue reading -> Exclusive: Vaccine Trial Against Sudan Ebolavirus – With No Recent Infections in Uganda, What’s Plan B? 23/12/2022 Elaine Ruth Fletcher The World Health Organization (WHO) isn’t talking about it publicly, but behind the scenes WHO is planning a meeting for 12 January to evaluate next steps, Health Policy Watch has learned, as the absence of new cases in the Uganda outbreak makes it impossible to begin a clinical trial based on a ring vaccination of […] Continue reading -> Uganda Extends Lockdowns in Bid to End Ebola Outbreak 28/11/2022 Stefan Anderson Uganda’s President Yoweri Museveni has extended quarantine measures in the two districts at the epicentre of the country’s Ebola epidemic for another 21 days, citing the need to protect gains in the fight against the virus. This marks the third renewal of lockdowns in Kassanda and Mubende, and authorities are hopeful it will be the […] Continue reading -> Trials of Three Ebola Candidate Vaccines Set for Uganda; India’s Covaxin Vaccine Still Suspended by WHO 16/11/2022 Megha Kaveri Clinical trials on three Ebola vaccine candidates for the Sudan strain of the virus are due to start soon in Uganda, according to the World Health Organization (WHO). “I’m pleased to announce that a WHO committee of external experts has evaluated three candidate vaccines and agreed that all three should be included in the planned […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
With End of Uganda Outbreak, There is No Clear Path to Test the Ebola Sudan Candidate Vaccines 13/01/2023 Kerry Cullinan There is no clear path to test the three candidate vaccines developed to combat the Ebola Sudan strain now that Uganda’s outbreak is over. The three candidate vaccines – produced by IAVI (called SUDV), Sabin (ChAD3) and Oxford (ChAdOx1) – were delivered to Uganda with much fanfare in mid-December. But scientists attending a meeting convened […] Continue reading -> Novel Ways to Advance Sudan Ebolavirus Vaccine Candidates? Experts Meet as Uganda’s Outbreak Declared Over 11/01/2023 Elaine Ruth Fletcher WHO’s Africa Region has declared the end to the recent outbreak of Sudan Ebolavirus – just a day before WHO convenes Ebola experts in a global consultation to explore a way forward on testing three candidate vaccines for the deadly Sudan strain of the virus. The oubreak was declared over after the elapse of 44 […] Continue reading -> Exclusive: Vaccine Trial Against Sudan Ebolavirus – With No Recent Infections in Uganda, What’s Plan B? 23/12/2022 Elaine Ruth Fletcher The World Health Organization (WHO) isn’t talking about it publicly, but behind the scenes WHO is planning a meeting for 12 January to evaluate next steps, Health Policy Watch has learned, as the absence of new cases in the Uganda outbreak makes it impossible to begin a clinical trial based on a ring vaccination of […] Continue reading -> Uganda Extends Lockdowns in Bid to End Ebola Outbreak 28/11/2022 Stefan Anderson Uganda’s President Yoweri Museveni has extended quarantine measures in the two districts at the epicentre of the country’s Ebola epidemic for another 21 days, citing the need to protect gains in the fight against the virus. This marks the third renewal of lockdowns in Kassanda and Mubende, and authorities are hopeful it will be the […] Continue reading -> Trials of Three Ebola Candidate Vaccines Set for Uganda; India’s Covaxin Vaccine Still Suspended by WHO 16/11/2022 Megha Kaveri Clinical trials on three Ebola vaccine candidates for the Sudan strain of the virus are due to start soon in Uganda, according to the World Health Organization (WHO). “I’m pleased to announce that a WHO committee of external experts has evaluated three candidate vaccines and agreed that all three should be included in the planned […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Novel Ways to Advance Sudan Ebolavirus Vaccine Candidates? Experts Meet as Uganda’s Outbreak Declared Over 11/01/2023 Elaine Ruth Fletcher WHO’s Africa Region has declared the end to the recent outbreak of Sudan Ebolavirus – just a day before WHO convenes Ebola experts in a global consultation to explore a way forward on testing three candidate vaccines for the deadly Sudan strain of the virus. The oubreak was declared over after the elapse of 44 […] Continue reading -> Exclusive: Vaccine Trial Against Sudan Ebolavirus – With No Recent Infections in Uganda, What’s Plan B? 23/12/2022 Elaine Ruth Fletcher The World Health Organization (WHO) isn’t talking about it publicly, but behind the scenes WHO is planning a meeting for 12 January to evaluate next steps, Health Policy Watch has learned, as the absence of new cases in the Uganda outbreak makes it impossible to begin a clinical trial based on a ring vaccination of […] Continue reading -> Uganda Extends Lockdowns in Bid to End Ebola Outbreak 28/11/2022 Stefan Anderson Uganda’s President Yoweri Museveni has extended quarantine measures in the two districts at the epicentre of the country’s Ebola epidemic for another 21 days, citing the need to protect gains in the fight against the virus. This marks the third renewal of lockdowns in Kassanda and Mubende, and authorities are hopeful it will be the […] Continue reading -> Trials of Three Ebola Candidate Vaccines Set for Uganda; India’s Covaxin Vaccine Still Suspended by WHO 16/11/2022 Megha Kaveri Clinical trials on three Ebola vaccine candidates for the Sudan strain of the virus are due to start soon in Uganda, according to the World Health Organization (WHO). “I’m pleased to announce that a WHO committee of external experts has evaluated three candidate vaccines and agreed that all three should be included in the planned […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Exclusive: Vaccine Trial Against Sudan Ebolavirus – With No Recent Infections in Uganda, What’s Plan B? 23/12/2022 Elaine Ruth Fletcher The World Health Organization (WHO) isn’t talking about it publicly, but behind the scenes WHO is planning a meeting for 12 January to evaluate next steps, Health Policy Watch has learned, as the absence of new cases in the Uganda outbreak makes it impossible to begin a clinical trial based on a ring vaccination of […] Continue reading -> Uganda Extends Lockdowns in Bid to End Ebola Outbreak 28/11/2022 Stefan Anderson Uganda’s President Yoweri Museveni has extended quarantine measures in the two districts at the epicentre of the country’s Ebola epidemic for another 21 days, citing the need to protect gains in the fight against the virus. This marks the third renewal of lockdowns in Kassanda and Mubende, and authorities are hopeful it will be the […] Continue reading -> Trials of Three Ebola Candidate Vaccines Set for Uganda; India’s Covaxin Vaccine Still Suspended by WHO 16/11/2022 Megha Kaveri Clinical trials on three Ebola vaccine candidates for the Sudan strain of the virus are due to start soon in Uganda, according to the World Health Organization (WHO). “I’m pleased to announce that a WHO committee of external experts has evaluated three candidate vaccines and agreed that all three should be included in the planned […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Uganda Extends Lockdowns in Bid to End Ebola Outbreak 28/11/2022 Stefan Anderson Uganda’s President Yoweri Museveni has extended quarantine measures in the two districts at the epicentre of the country’s Ebola epidemic for another 21 days, citing the need to protect gains in the fight against the virus. This marks the third renewal of lockdowns in Kassanda and Mubende, and authorities are hopeful it will be the […] Continue reading -> Trials of Three Ebola Candidate Vaccines Set for Uganda; India’s Covaxin Vaccine Still Suspended by WHO 16/11/2022 Megha Kaveri Clinical trials on three Ebola vaccine candidates for the Sudan strain of the virus are due to start soon in Uganda, according to the World Health Organization (WHO). “I’m pleased to announce that a WHO committee of external experts has evaluated three candidate vaccines and agreed that all three should be included in the planned […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Trials of Three Ebola Candidate Vaccines Set for Uganda; India’s Covaxin Vaccine Still Suspended by WHO 16/11/2022 Megha Kaveri Clinical trials on three Ebola vaccine candidates for the Sudan strain of the virus are due to start soon in Uganda, according to the World Health Organization (WHO). “I’m pleased to announce that a WHO committee of external experts has evaluated three candidate vaccines and agreed that all three should be included in the planned […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy